Federated Hermes, Inc. (FHI) 13D/13G Filings for Seres Therapeutics, Inc. (MCRB)

Federated Hermes, Inc. 13D and 13G filings for Seres Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-11-07
12:57 pm
Sale		 2023-10-31 13G Seres Therapeutics, Inc.
MCRB		 FEDERATED HERMES INC.
FHI		 258,790
4.040%		 -316,236decrease
(-55.00%)		 Filing
2023-05-10
10:16 am
Sale		 2023-04-30 13G Seres Therapeutics, Inc.
MCRB		 FEDERATED HERMES INC.
FHI		 575,026
9.000%		 -329,271decrease
(-36.41%)		 Filing
2023-02-01
12:15 pm
Purchase		 2022-12-31 13G Seres Therapeutics, Inc.
MCRB		 FEDERATED HERMES INC.
FHI		 904,297
14.520%		 5,184increase
(+0.58%)		 Filing
2022-07-11
2:13 pm
Purchase		 2022-06-30 13G Seres Therapeutics, Inc.
MCRB		 FEDERATED HERMES INC.
FHI		 899,113
14.500%		 553,406increase
(+160.08%)		 Filing
2022-02-14
1:46 pm
Purchase		 2021-12-31 13G Seres Therapeutics, Inc.
MCRB		 FEDERATED HERMES INC.
FHI		 345,707
7.530%		 345,707increase
(New Position)		 Filing